Table 5. Multivariate analysis of clinicopathological and genetic parameters for OS (Cox regression hazard analysis).
OS
|
|||
---|---|---|---|
Prognostic factor | P-values | Hazard ratio | 95% CI |
Step 1 | |||
pT category | |||
T3/4 | 0.27 | 2 | 0.6–6.3 |
pN category | |||
N2/3 | 0.001 | 2.3 | 1.4–3.8 |
Differentiation | |||
G3/4 | 0.18 | 1.4 | 0.9–2.4 |
Treatment arm | |||
Arm B (5-FU/LEV) | 0.02 | 1.8 | 1.1–3.8 |
BSI | |||
Low | 0.004 | 2.1 | 1.3–3.4 |
Step 3 | |||
pN category | |||
N2/3 | <0.0001 | 2.5 | 1.5–4.2 |
BSI | |||
Low | 0.003 | 2.1 | 1.3–3.5 |
Treatment arm | |||
Arm B (5-FU/LEV) | 0.01 | 1.9 | 1.1–3.1 |
CI=confidence interval; 5-FU=5-fluorouracil; LEV=levamisole; OS=overall survival. Bold values signify P<0.05.